Table 2 shows that in male NSTE-ACS patients, differences in diabetes, hyperlipidemia, gout/hyperuricemia, cerebral infarction, smoking, TG, apolipoprotein B/A, HDL-C, blood glucose, uric acid, cystatin C, cTnT, monocytes, NLR, LVEF, and MHR were statistically significant between low-risk and high-risk groups (p < 0.05). This evidence concerns the gene CST3 and cerebral infarction.